Ledipasvir plus sofosbuvir: Hint of added benefit in further patient group
Documents subsequently submitted by the manufacturer show advantage in SVR also for genotype 1 with HIV coinfection without cirrhosis of the liver
2015-05-22
(Press-News.org) The German Institute for Quality and Efficiency in Health Care (IQWiG) has assessed documents subsequently submitted by the drug manufacturer in the commenting procedure on the dossier assessment of the fixed-dose drug combination of ledipasvir and sofosbuvir (trade name: Harvoni). According to the findings, a hint of a non-quantifiable added benefit for a further patient group can be derived from this additional information.
This patient group consists of treatment-naive or pretreated patients with hepatitis C virus (HCV) infection of genotype 1 who are also infected with HIV, but have not yet developed cirrhosis of the liver. For genotype 1 patients (without cirrhosis) who have no HIV coinfection, IQWiG had already determined an added benefit in the dossier assessment.
Results are transferable
In the commenting procedure, the pharmaceutical company had submitted further documents on a total of five studies to the G-BA. In comparison with the dossier assessment, this additional information changed the result for one of the seven patient groups differentiated by the G-BA: It shows that the results on the outcome "sustained virologic response" (SVR) for patients without HIV coinfection are transferable to patients with HIV coinfection. However, this only applies if these patients have not yet developed cirrhosis of the liver. For patients with cirrhosis of the liver, sufficient and evaluable data are still not available.
Extent of added benefit non-quantifiable
It still remains unclear, however, in how many patients in whom the virus is no longer detectable, late complications, and liver cancer in particular, can actually be prevented. Therefore the extent of added benefit is "non-quantifiable".
Due to the advantage in SVR, IQWiG had already derived a hint of a non-quantifiable added benefit in two patient groups in the dossier assessment: for patients with HCV infection of genotype 1 when previous therapies have been unsuccessful, and for treatment-naive patients who have not yet developed cirrhosis of the liver.
INFORMATION:
G-BA decides on the extent of added benefit
The dossier assessment is part of the early benefit assessment according to the Act on the Reform of the Market for Medicinal Products (AMNOG) supervised by the G-BA. After publication of the manufacturer's dossier and the IQWiG dossier assessment, the manufacturer submitted additional information in the commenting procedure. The G-BA subsequently commissioned IQWiG to assess the data subsequently submitted. IQWiG now presents this assessment in the form of an addendum. The G-BA makes a final decision on the extent of added benefit.
ELSE PRESS RELEASES FROM THIS DATE:
2015-05-22
A larger brain brings better cognitive performance. And so it seems only logical that a larger brain would offer a higher survival potential. In the course of evolution, large brains should therefore win out over smaller ones. Previous tests of this hypothesis had relied on comparison studies looking at the intelligence and survival potential of species with large brains versus species with smaller brains. And species with larger brains do appear to have an advantage. But such studies are unable to show a causal relationship.
Alexander Kotrschal, Sarah Zala, Séverine ...
2015-05-22
Increasing public knowledge and understanding about energy issues is vital if improved energy-saving behaviours are to be encouraged among individuals and organisations, a study suggests.
A survey conducted at Plymouth University indicated widespread misconceptions about energy which researchers said may be reducing the effectiveness of energy-saving behaviours.
It also showed varying levels of motivation and engagement with energy issues, with respondents saying they were uncertain about their capacity to influence business and government on matters of environmental ...
2015-05-22
An association between resting heart rate and diabetes suggests that heart rate measures could identify individuals with a higher future risk of diabetes, according to an international team of researchers.
In a four-year study of 73,357 Chinese adults, researchers observed that faster heart rates were positively associated with an increased risk of developing diabetes. Researchers also found that faster heart rates were associated with impaired fasting glucose levels and a conversion from impaired fasting glucose levels to diabetes among the same population.
"In this ...
2015-05-22
In a special issue, The Anatomical Record ventures into the world of human mummified remains. In 26 articles, the anatomy of mummies is exquisitely detailed through cutting edge examination, while they are put in historical, archeological, and cultural context. Investigators even take on the thorny issue of ethics as it applies to human remains in general and to the specific case of mummy research.
The eyes and tools of the 21st century meet the world of the past and allow one to think of mummies as more than just museum displays shrouded in mystery and fascination. ...
2015-05-22
A new article publishing online today in the Quarterly Journal of Medicine has reported the first case showing an association between exposure to head injuries in rugby union players and an increased risk in neurodegenerative disease.
Until now, the association between head injuries and neurodegenerative disease, specifically chronic traumatic encephalopathy (CTE), has predominantly been made with boxers. However Dr Michael Farrell and colleagues have presented the first comprehensive case report of CTE in a former amateur rugby union player, who died six years after ...
2015-05-22
Sophia Antipolis, 22 May 2015: Urgent diagnosis and treatment in acute heart failure has been emphasised for the first time in joint recommendations published today in European Heart Journal.1
The consensus paper is the result of a novel collaboration between the Heart Failure Association (HFA) of the European Society of Cardiology (ESC), the European Society for Emergency Medicine and the Society for Academic Emergency Medicine in the USA.
Professor Alexandre Mebazaa, lead author and HFA board member, said: "This is the first guidance to insist that acute heart failure ...
2015-05-22
Blood pressure lowering drugs do not improve life expectancy among adults with diabetes and kidney disease, a new study of the global evidence published today in The Lancet reveals.
However, the study, which brings together 157 studies involving more than 43,000 adults with diabetes, shows that angiotensin-converting-enzyme (ACE) inhibitors and angiotensin-receptor blocker (ARB) treatments, alone or in combination, are the most effective drug regimen for preventing end-stage kidney disease -- an important finding given that diabetes is now the leading cause of people ...
2015-05-22
A study by researchers from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King's College London has shown that mood instability occurs in a wide range of mental disorders and is not exclusive to affective conditions such as depression, bipolar disorder and anxiety disorder.
The research, published today in BMJ Open, also found that mood instability was associated with poorer clinical outcomes.
Taken together, these findings suggest that clinicians should screen for mood instability across all common mental health disorders. Targeted interventions ...
2015-05-21
BUFFALO, N.Y. - Smokers are four times more likely than non-smokers to become frequent visitors of emergency rooms.
That is one of the findings uncovered by a preliminary study led by Jessica Castner, a University at Buffalo emergency room utilization researcher.
The research - which sought to shed light on whether patients are replacing visits to their primary care physicians with trips to hospital ERs- also found that Americans with chronic diseases use both services equally and that, overall, medical care visits have soared in recent years.
"There are a few super-users ...
2015-05-21
Imagine someone hands you a smoothie and asks you to identify everything that went into it.
You might be able to discern a hint of strawberry or the tang of yogurt. But overall it tastes like a blend of indiscernible ingredients.
Now imagine that the smoothie is made of 20,000 ground-up cells from, say, the brain.
You could run tests to determine what molecules are in the sample, which is what scientists do now. That would certainly give you useful information, but it wouldn't tell you which cells those molecules originally came from. It would provide only an average ...
LAST 30 PRESS RELEASES:
[Press-News.org] Ledipasvir plus sofosbuvir: Hint of added benefit in further patient group
Documents subsequently submitted by the manufacturer show advantage in SVR also for genotype 1 with HIV coinfection without cirrhosis of the liver
